Allogene Therapeutics, Inc. acknowledged the passing of founding board member, David Bonderman. David died at the age of 82, surrounded by his family. A steadfast advocate for CAR T-cell therapy, David?s contributions to Allogene are immeasurable.

He served on Allogene?s Board of Directors since its founding in 2018, taking on the role of Lead Independent Director. In this capacity, he championed innovation, provided trusted mentorship, and served as a constant source of inspiration to all who worked alongside him.